We are excited to announce the launch of CircBioCare, an innovative research project dedicated to transforming early knee osteoarthritis (OA) diagnosis and treatment. With OA affecting over 500 million people worldwide, early detection is crucial to slowing disease progression and improving patient outcomes.
A New Approach to OA Diagnosis
Current diagnostic tools, such as X-rays and MRIs, are expensive and only useful in later stages of the disease. CircBioCare is changing the game by developing cutting-edge molecular assays that detect OA before symptoms appear. By analyzing miRNA and protein biomarkers in blood, we aim to create personalized diagnostic tools tailored to different OA types.
Harnessing Advanced Technologies
Our research integrates AI, machine learning, and multiomics to identify reliable biomarkers and design precision medicine solutions. Additionally, we are studying the role of the infrapatellar fat pad (IPFP) in OA progression, offering new insights into disease mechanisms.
Collaboration: the key tool
CircBioCare brings together leading universities, medical centers, and industry partners to bridge the gap between research and real-world application. By involving patients and stakeholders, we ensure our innovations are both effective and widely accepted.
Looking Ahead
Our ultimate goal is to provide affordable, accessible, and early OA detection tools, empowering healthcare professionals and patients alike. Stay tuned for updates as we advance toward a future where early intervention and personalized treatment become the standard for OA care.
Want to learn more or collaborate with us? Get in touch!
Visit Our New Website!
We are also thrilled to launch the CircBioCare website, where you can stay updated on the latest developments, research findings, and project milestones. Our website will serve as the central hub for news, publications, and collaborations, keeping you informed every step of the way.
